NuScale Power vs. Oklo: Which Nuclear Stock Is a Better Buy in 2026?

The article compares NuScale Power and Oklo as long-duration bets on AI-driven data center electricity demand, with Oklo favored due to stronger DOE collaborations, Nvidia ties, and more than $2 billion in cash. NuScale has NRC design certification and a pipeline via ENTRA1, but it remains pre-revenue, loss-making, and dependent on milestone payments. Both names are highly speculative, but the piece argues Oklo has slightly better operational progress and partnership support.

Analysis

The market is beginning to treat advanced nuclear less like a pure regulatory story and more like an option on data-center power scarcity. That changes the winner set: the companies with the best funding runway and the most credible path to becoming a platform, not just a reactor vendor, deserve the premium. In that framing, OKLO is better positioned than SMR because the former is building an ecosystem around fuel services, permitting, and hyperscaler relationships, which creates multiple shots on goal if only one project clears the gate.

The second-order effect is that the real bottleneck is no longer reactor design approval; it is execution velocity across siting, fuel handling, and utility interconnects. That tends to favor names with balance-sheet flexibility and government program access, because the timeline from “policy enthusiasm” to “revenue recognition” is easily a multi-year gap. SMR’s certification is useful defensively, but absent binding deployment economics it risks becoming a valuation anchor rather than a catalyst.

The contrarian view is that the more crowded trade may be the obvious nuclear builder, while the underappreciated beneficiary is the adjacent infrastructure stack: data-center operators, power equipment, and uranium/fuel-cycle beneficiaries that get paid while these projects remain in development. For the equity itself, the base case is still speculative and sentiment-driven, but OKLO has a clearer path to rerating if it converts pilot-program credibility into a permitted first site over the next 6-12 months. The main reversal risk is not “nuclear bad,” but schedule slippage that turns both names into cash-burn stories and compresses multiple expansion.

On balance, this is a momentum trade with a fundamental tailwind, but the valuation asymmetry is severe enough that entry discipline matters. Any disappointment in regulatory milestones or partner execution could cut these names 30-50% quickly, because the current market cap is effectively pre-paying for success that has not yet been de-risked.

Key Decisions for Investors

• Prefer long OKLO over SMR on a 6-12 month horizon; the pair offers better catalyst density and a cleaner funding runway. Use a small initial size because downside on permitting delays can still be 30-40%.
• Pair trade: long OKLO / short SMR into strength. Thesis: OKLO has more credible commercial optionality, while SMR’s certification advantage is already embedded and can become a value trap if contracts lag.
• Buy downside protection on SMR rather than outright shorting it. 3-6 month puts provide a defined-risk way to express the view that certification alone will not close the gap to revenue.
• Watch META and EQIX as indirect beneficiaries; if hyperscaler power procurement accelerates, these names gain operational leverage even if nuclear timelines slip. Use them as lower-volatility exposure to the same theme.
• Do not chase after any single positive regulatory headline. Wait for site-level permitting, fuel-cycle approvals, or binding offtake evidence before adding aggressively; until then, the risk/reward is dominated by narrative beta.